Admin Core
Admin Core
批准号:
10006207
负责人:
Peter Leif Bergsagel
金额:
$8.37万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-09-01 至 2022-08-31
关键词:
AdherenceAdministratorAdvocateArizonaAwarenessClinicCollaborationsCommunicationCommunitiesDataDevelopmentDrug resistanceEnsureEvaluationGenomeGoalsInformation DisseminationInfrastructureLeadershipMalignant NeoplasmsManuscriptsMinnesotaMultiple MyelomaOccupational activity of managing financesPatient-Focused OutcomesPatientsPharmaceutical PreparationsPhysiciansPublicationsReportingResearchResearch PersonnelResearch Project GrantsResistanceResource SharingStructureTranslational ResearchUniversitiesWorkdata sharingdesigndrug sensitivityimproved outcomeinnovationmembernovel strategiesoperationprecision medicineresponsesuccess
中文摘要
管理核心摘要
行政核心将提供必要的组织基础设施,促进和整合
在这3个项目药物敏感性和耐药性中心(DSRC)的研究,支持药物分析,
多发性骨髓瘤(MM)的反应和耐药性;并加快开发治疗MM的新策略。
精准医疗行政核心将通过提供领导、财政和技术支持,
管理,以及旨在有效协调DSRC活动的行政结构
项目,以及向医生、其他研究人员和患者传播信息
社区管理核心将协调DSRC网络成员之间的通信。
具体而言,行政核心分配所有DSRC账户和分包合同,并通过行政核心分配所有DSRC账户和分包合同。
委员会由3名项目负责人、一名运营管理员和一名患者倡导者组成,
评估进展,确保资源和数据共享,审查项目数据和出版物手稿。
英文摘要
ADMINISTRATION CORE ABSTRACT
The Administration Core will provide the organizational infrastructure necessary to promote and integrate the
research in this 3 Project Drug Sensitivity and Resistance Center (DSRC), supporting analysis of drug
response and resistance in multiple myeloma (MM); and to expedite the development of novel strategies in
precision medicine. The Administration Core will facilitate activities by providing leadership, financial
management, and an administrative structure designed to efficiently coordinate the activities of the DSRC
projects, as well as the dissemination of information to physicians, other researchers and the patient
community. The Administrative Core will coordinate communication among the DSRC Network members.
Specifically, the Administrative Core assigns all DSRC accounts and subcontracts, and through the Executive
Committee, composed of the 3 Project Leaders, an Operations Administrator, and a patient advocate will
evaluate progress, ensure resource and data sharing, review project data and manuscripts for publications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
preclinical optimization of BCMA directed T cell therapy
-
批准号:10802050
-
项目类别:
-
资助金额:$62.19万
-
财政年份:2023
-
负责人:Peter Leif Bergsagel
-
依托单位:
Admin Core
-
批准号:10494370
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:10006064
-
项目类别:
-
资助金额:$118.03万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:10414667
-
项目类别:
-
资助金额:$8.33万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Overcoming Drug Resistance in Multiple Myeloma
-
批准号:9985240
-
项目类别:
-
资助金额:$131.16万
-
财政年份:2017
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10488637
-
项目类别:
-
资助金额:$203.16万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Administrative Core
-
批准号:10270452
-
项目类别:
-
资助金额:$12.15万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mutations that Distinguish Benign from Malignant Plasma Cell Neoplasams
-
批准号:9194396
-
项目类别:
-
资助金额:$37.97万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Oncolytic Virotherapy for Multiple Myeloma using VSV
-
批准号:8930233
-
项目类别:
-
资助金额:$35.87万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10706314
-
项目类别:
-
资助金额:$197.64万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:10270451
-
项目类别:
-
资助金额:$209.12万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Project 3: Early detection and prevention of MM progression
-
批准号:10270457
-
项目类别:
-
资助金额:$39.68万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Administrative Core
-
批准号:10488639
-
项目类别:
-
资助金额:$12.04万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Administrative Core
-
批准号:10706317
-
项目类别:
-
资助金额:$12.05万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Mayo Clinic Multiple Myeloma SPORE
-
批准号:9331487
-
项目类别:
-
资助金额:$230.0万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Project 3: Early detection and prevention of MM progression
-
批准号:10488670
-
项目类别:
-
资助金额:$33.73万
-
财政年份:2015
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8061624
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8250027
-
项目类别:
-
资助金额:$32.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:8462114
-
项目类别:
-
资助金额:$30.27万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
Molecular Pathogenesis of Multiple Myeloma
-
批准号:7736610
-
项目类别:
-
资助金额:$33.2万
-
财政年份:2009
-
负责人:Peter Leif Bergsagel
-
依托单位:
海外基金